Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Feb 3, 2024
Date Accepted: Sep 20, 2024

The final, peer-reviewed published version of this preprint can be found here:

Coproduction in Social Prescribing Initiatives: Protocol for a Scoping Review

Dougherty M, Tompkins T, Zibrowski E, Cram J, Ashe MC, Bhaskar LT, Card K, Godfrey C, Hebert P, Lacombe R, Muhl C, Mulligan K, Mulvale G, Nelson M, Norman M, Symes B, Teare G, Welch V, Kothari A

Coproduction in Social Prescribing Initiatives: Protocol for a Scoping Review

JMIR Res Protoc 2024;13:e57062

DOI: 10.2196/57062

PMID: 39419498

PMCID: 11528170

Co-production in social prescribing initiatives: protocol for a scoping review

  • Madeline Dougherty; 
  • Tamara Tompkins; 
  • Elaine Zibrowski; 
  • Jesse Cram; 
  • Maureen C Ashe; 
  • Le-Tien Bhaskar; 
  • Kiffer Card; 
  • Christina Godfrey; 
  • Paul Hebert; 
  • Ron Lacombe; 
  • Caitlin Muhl; 
  • Kate Mulligan; 
  • Gillian Mulvale; 
  • Michelle Nelson; 
  • Myrna Norman; 
  • Bobbi Symes; 
  • Gary Teare; 
  • Vivian Welch; 
  • Anita Kothari

ABSTRACT

Background:

Social Prescribing (SP) takes a holistic approach to health by linking clients from clinical settings to community programs to address their non-medical needs. The emerging evidence base for SP demonstrates variability in the design and implementation of different SP initiatives. To effectively address these needs, co-production among clients, communities, stakeholders, and policymakers is important for tailoring SP initiatives for optimal uptake.

Objective:

To explore the role of co-production in SP initiatives. The research question is: how and for what purpose has co-production been incorporated across a range of SP initiatives for different clients?

Methods:

A review of international literature will be conducted following the JBI guidelines for scoping reviews. We will search multiple databases including Scopus, Medline, and the PAIS Index, as well as grey literature from 2000-2023. The primary studies included will describe a non-medical need for clients, a non-medical SP program or initiative, co-production of the SP program and any follow up. Review articles and commentaries will be excluded. Titles, abstracts, and full-text articles will be screened, and data will be extracted by at least two research team members using Covidence, and a pilot-tested extraction template. Clients with lived experience will also participate in the research process. Findings will be descriptively summarized and thematically synthesized to answer the research question.

Results:

At this time we do not have results, but expect them by the end of 2024.

Conclusions:

Descriptions of what co-production is meant to accomplish may differ from theoretical aspirations. Continued understanding of how co-production has been designed and executed across varied international SP models is important for framing engagement in practice for future SP arrangements, and their evaluation. We anticipate this review will guide clients, communities, stakeholders, and policymakers in further developing SP practice within healthcare systems.


 Citation

Please cite as:

Dougherty M, Tompkins T, Zibrowski E, Cram J, Ashe MC, Bhaskar LT, Card K, Godfrey C, Hebert P, Lacombe R, Muhl C, Mulligan K, Mulvale G, Nelson M, Norman M, Symes B, Teare G, Welch V, Kothari A

Coproduction in Social Prescribing Initiatives: Protocol for a Scoping Review

JMIR Res Protoc 2024;13:e57062

DOI: 10.2196/57062

PMID: 39419498

PMCID: 11528170

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.